TEVA PHARMACEUTICAL INDUSTRIES LTD Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Teva Pharmaceutical Industries Ltd quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Teva Pharmaceutical Industries Ltd Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$846M, a 2.98% increase year-over-year.
  • Teva Pharmaceutical Industries Ltd Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$452M, a 80.6% increase year-over-year.
  • Teva Pharmaceutical Industries Ltd annual Net Income (Loss) Attributable to Parent for 2023 was -$559M, a 77.1% increase from 2022.
  • Teva Pharmaceutical Industries Ltd annual Net Income (Loss) Attributable to Parent for 2022 was -$2.45B, a 687% decline from 2021.
  • Teva Pharmaceutical Industries Ltd annual Net Income (Loss) Attributable to Parent for 2021 was $417M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$559M +$1.89B +77.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-12
2022 -$2.45B -$2.86B -687% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-12
2021 $417M +$4.41B Jan 1, 2021 Dec 31, 2021 10-K 2024-02-12
2020 -$3.99B -$2.99B -299% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 -$999M +$1.15B +53.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 -$2.15B +$14.1B +86.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-10
2017 -$16.3B -$16.6B -5044% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $329M -$1.26B -79.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-12
2015 $1.59B -$1.47B -48% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-12
2014 $3.06B +$1.79B +141% Jan 1, 2014 Dec 31, 2014 20-F 2017-02-15
2013 $1.27B -$694M -35.4% Jan 1, 2013 Dec 31, 2013 20-F 2016-02-11
2012 $1.96B -$796M -28.9% Jan 1, 2012 Dec 31, 2012 20-F 2015-02-09
2011 $2.76B -$572M -17.2% Jan 1, 2011 Dec 31, 2011 20-F 2014-02-10
2010 $3.33B Jan 1, 2010 Dec 31, 2010 20-F 2013-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.